A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS).

Seyed-Mahdi Khaligh-RazaviMaryam SadeghiMahdiyeh KhanbagiChris KalafatisSeyed Massood Nabavi

Published in: BMC neurology (2020)

The ICA has the potential to be used as a digital marker of cognitive impairment and to monitor response to therapeutic interventions. In comparison to standard cognitive tools for MS, the ICA is shorter in duration, does not show a learning bias, and is independent of language.

Keyphrases

artificial intelligence
multiple sclerosis
cognitive impairment
machine learning
big data
deep learning
mass spectrometry
ms ms
white matter
autism spectrum disorder
high throughput
clinical evaluation